COMP <GO>
OSCR vs GRAL // FREE CASH FLOW YIELD
Oscar Health Inc. (NYSE) VS. GRAIL Inc. (NASDAQ) • 15-METRIC TALLY: OSCR 3
— GRAL 5
▲ FREE CASH FLOW YIELD LEADER: OSCR
LAST: $30.79 (+1.02%) • MKT CAP: $9.50B
fcf-yield
11.51%
LAST: $158.92 (+0.66%) • MKT CAP: $7.10B
fcf-yield
-4.23%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OSCR VS. GRAL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OSCR | GRAL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -18.00% | -17.00 | GRAL | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 11.51% | -4.23% | +15.74 | OSCR | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 39.00% | 17.20% | +21.80 | OSCR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 7.26 | -6.81 | GRAL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.2 | 63.7 | -19.50 | GRAL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 1.00 | -0.03 | GRAL | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.0x | 22.0x | +1.00 | GRAL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.50B | $7.10B | $2.40B | OSCR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OSCR REV | GRAL REV | OSCR GROSS % | GRAL GROSS % | OSCR FCF | GRAL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $28.6M | $147.2M | — | — | $1.09B | -$299.9M |
| FY 2024 | $20.6M | $125.6M | — | — | $977.3M | -$582.4M |
| FY 2023 | $21.4M | $93.1M | — | — | -$273.1M | -$600.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OSCR // BETA 0.97
GRAL // BETA 1.00